123. Oncol Rev. 2018 Jan 30;12(1):345. doi: 10.4081/oncol.2018.345. eCollection 2018Jan 30.Punica granatum (Pomegranate) activity in health promotion and cancer prevention.Bassiri-Jahromi S(1).Author information: (1)Medical Mycology Department, Pasteur Institute of Iran, Thran, Iran.Cancer has become one of the most fatal diseases in most countries. In spite ofthe medical care developing, cancer still remains a significant problem. Themajority of the cancers are resistant to treatment. Thus, the research for novel,more efficient and less side effect treatment methods continues. Pomegranatecontains strong antioxidant activity, with potential health interests. Researchconcern in pomegranate is increasing because of their anticancer potential due topossess rich in polyphenols. We highlight the pomegranate potential healthbenefits and mechanism of cancer progression inhibition. Pomegranate hasindicated antiproliferative, anti-metastatic and anti-invasive effects ondifferent cancer cell line in vitro, in vivo and clinical trial. The aim of this review is to evaluate functional properties and the medical benifits ofpomegranate against various cancer diseases. In addition, pomegranate properties in in vitro and in vivo experimental human and animal clinical trials and itsfuture use are explored. The available data suggest that Punica granatum(pomegranate) might be used in the control and potential therapeutic for somedisease conditions and benefits human health status. This review summarizes invitro, in vivo and clinical trial studies highlighting the pomegranate role inprevent and treatment of breast, prostate, lung, colon, skin and hepatocellularcell cancers.DOI: 10.4081/oncol.2018.345 PMCID: PMC5806496PMID: 29441150 